CXCL10 and CXCL11 are known to attenuate bleomycin-induced pulmonary fibrosis [34] and were increased by 25- and >10-fold, respectively, reflecting antifibrotic activity of Ad-p53. The gene discussed is CXCL11; the disease is pulmonary fibrosis.